These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9832297)

  • 21. High-performance liquid chromatography of dipyrone and its active metabolite in biological fluids.
    Asmardi G; Jamali F
    J Chromatogr; 1983 Oct; 277():183-9. PubMed ID: 6643604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profiles of the active metamizole metabolites in healthy horses.
    Giorgi M; Aupanun S; Lee HK; Poapolathep A; Rychshanova R; Vullo C; Faillace V; Laus F
    J Vet Pharmacol Ther; 2017 Apr; 40(2):165-171. PubMed ID: 27477925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of dipyrone metabolites in rat hypothalamus, cerebrospinal fluid and plasma samples by LC-MS/MS.
    Aguiar FA; Malvar Ddo C; Vaz Ade L; Calixto LA; Clososki GC; de Gaitani CM; de Souza GE; Jabor VA
    Bioanalysis; 2013 Nov; 5(21):2631-45. PubMed ID: 24180504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).
    Volz M; Kellner HM
    Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):299S-308S. PubMed ID: 7002187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole.
    Ariza A; García-Martín E; Salas M; Montañez MI; Mayorga C; Blanca-Lopez N; Andreu I; Perkins J; Blanca M; Agúndez JA; Torres MJ
    Sci Rep; 2016 Mar; 6():23845. PubMed ID: 27030298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrazolone derivatives.
    Brogden RN
    Drugs; 1986; 32 Suppl 4():60-70. PubMed ID: 3552586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on HPLC method for determination of 4-methylaminoantipyrine and relative bioavailabilities of analgin nasal drops in human volunteers].
    Cui JB; Xi NZ; Jiang XG
    Yao Xue Xue Bao; 1997; 32(1):65-8. PubMed ID: 11243223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of food on the pharmacokinetics of dipyrone.
    Flusser D; Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1988; 34(1):105-7. PubMed ID: 3360045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products.
    Gómez MJ; Sirtori C; Mezcua M; Fernández-Alba AR; Agüera A
    Water Res; 2008 May; 42(10-11):2698-706. PubMed ID: 18294672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of 4-methylaminoantipyrine, the active metabolite of dipyrone, in human plasma.
    Ojha A; Rathod R; Padh H
    Bioanalysis; 2009 May; 1(2):293-8. PubMed ID: 21083168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The determination of aminopyrine and dipyrone metabolites.
    Zylber-Katz E; Levy M
    Ther Drug Monit; 1996 Feb; 18(1):103-4. PubMed ID: 8848812
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of aminopyrine and dipyrone metabolites in urine.
    Agúndez JA; Benítez J
    Ther Drug Monit; 1996 Feb; 18(1):104-7. PubMed ID: 8848813
    [No Abstract]   [Full Text] [Related]  

  • 34. Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test.
    Herdeg C; Hilt F; Büchtemann A; Bianchi L; Klein R
    Liver; 2002 Dec; 22(6):507-13. PubMed ID: 12445177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets.
    Burmańczuk A; Kowalski C; Giorgi M; Owen H; Grabowski T
    J Vet Pharmacol Ther; 2016 Dec; 39(6):616-620. PubMed ID: 27199202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules.
    Artaza MA; Puerta JL; Ortiz R; Laporte JR
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):322-6. PubMed ID: 12139210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited-sampling strategy models for estimating the pharmacokinetic parameters of 4-methylaminoantipyrine, an active metabolite of dipyrone.
    Suarez-Kurtz G; Ribeiro FM; Estrela RC; Vicente FL; Struchiner CJ
    Braz J Med Biol Res; 2001 Nov; 34(11):1475-85. PubMed ID: 11668360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
    Levy M; Leibowich I; Zylber-Katz E; Ilan Y; Granit L; Sviri S; Caraco Y
    Clin Pharmacol Ther; 1997 Jul; 62(1):6-14. PubMed ID: 9246014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic study of dipyrone metabolite 4-MAA in the horse and possible implications for doping control.
    Klaus AM; Schlingloff Y; Kleinitz U; Böttcher M; Hapke HJ
    J Vet Pharmacol Ther; 1997 Jun; 20(3):204-8. PubMed ID: 9185086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
    Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.